Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 379

1.

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C.

Curr Stem Cell Res Ther. 2013 Mar;8(2):144-55. Review.

PMID:
23279098
2.

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.

Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9.

3.

Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

Lo Iacono M, Anzalone R, La Rocca G, Baiamonte E, Maggio A, Acuto S.

Stem Cell Rev. 2017 Feb;13(1):35-49. doi: 10.1007/s12015-016-9702-4. Review.

PMID:
27853939
4.

Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R.

BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18.

5.

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.

Regen Med. 2014;9(6):723-32. doi: 10.2217/rme.14.60.

PMID:
25431909
6.

Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?

El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V.

Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22. Review.

PMID:
24552279
7.

Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.

Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A.

Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10. Review.

PMID:
26482184
8.

Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.

Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S.

Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1. Epub 2014 Feb 17.

PMID:
24532125
9.

Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.

Margossian T, Reppel L, Makdissy N, Stoltz JF, Bensoussan D, Huselstein C.

Biomed Mater Eng. 2012;22(4):243-54. doi: 10.3233/BME-2012-0714.

PMID:
22785368
10.

Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.

Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV.

Int J Mol Sci. 2013 May 31;14(6):11692-712. doi: 10.3390/ijms140611692. Review.

11.

Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.

Donders R, Vanheusden M, Bogie JF, Ravanidis S, Thewissen K, Stinissen P, Gyselaers W, Hendriks JJ, Hellings N.

Cell Transplant. 2015;24(10):2077-98. doi: 10.3727/096368914X685104. Epub 2014 Oct 10.

PMID:
25310756
12.

A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.

Roy S, Arora S, Kumari P, Ta M.

Cryobiology. 2014 Jun;68(3):467-72. doi: 10.1016/j.cryobiol.2014.03.010. Epub 2014 Apr 4.

PMID:
24704519
13.

Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells.

Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan MC, Borlongan CV.

Cytotherapy. 2015 Jan;17(1):18-24. doi: 10.1016/j.jcyt.2014.08.009. Epub 2014 Oct 18. Review.

14.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
15.

Role of Nonmuscle Myosin II in Migration of Wharton's Jelly-Derived Mesenchymal Stem Cells.

Arora S, Saha S, Roy S, Das M, Jana SS, Ta M.

Stem Cells Dev. 2015 Sep 1;24(17):2065-77. doi: 10.1089/scd.2015.0095. Epub 2015 Jun 4.

16.

Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.

Bakhshi T, Zabriskie RC, Bodie S, Kidd S, Ramin S, Paganessi LA, Gregory SA, Fung HC, Christopherson KW 2nd.

Transfusion. 2008 Dec;48(12):2638-44. doi: 10.1111/j.1537-2995.2008.01926.x. Epub 2008 Sep 16.

17.

Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.

Bharti D, Shivakumar SB, Park JK, Ullah I, Subbarao RB, Park JS, Lee SL, Park BW, Rho GJ.

Cell Tissue Res. 2018 Apr;372(1):51-65. doi: 10.1007/s00441-017-2699-4. Epub 2017 Dec 4.

18.

Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jelly.

Trivanović D, Kocić J, Mojsilović S, Krstić A, Ilić V, Djordjević IO, Santibanez JF, Jovcić G, Terzić M, Bugarski D.

Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86.

19.

Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.

Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S.

Intern Med J. 2013 Apr;43(4):430-9. doi: 10.1111/imj.12044.

PMID:
23176558
20.

Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.

Cell Tissue Res. 2011 Oct;346(1):53-64. doi: 10.1007/s00441-011-1249-8. Epub 2011 Oct 11.

PMID:
21987220

Supplemental Content

Support Center